Benjamin Hohl - CHIEF FINANCIAL OFFICER at Enliven Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
ELVN on Nasdaq
All Insider Reports
All Insider Reports

Benjamin Hohl - trading volume in the past year for Enliven Therapeutics, Inc.

Holdings reported by Benjamin Hohl for Enliven Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 0 $0 $27.53 Jul 31, 2024 Direct
Stock Option (right to buy) 203K Jul 31, 2024 Direct Common Stock

Transactions reported by Benjamin Hohl for Enliven Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership